Gladiator Therapeutics

Gladiator Therapeutics is dedicated to the research and innovation of non-powered far infrared (FIR) technology to develop therapies for stem cell proliferation, treating surgical post-operative and chronic wounds. The patented SemiCera(TM) Technology offers a new alternative to improve a patient's quality of life while reducing costs associated with treating wounds.

Blessed with novel technology, we continue to advance and explore medical applications through ongoing clinical trials and case studies. Our intention is to develop medical devices using this non-powered FIR technology based on scientific evidence for a variety of indications including wound healing and physical recovery from tissue damage or surgical recovery.

Prof. Carrick mentions Gladiator as an application for Parkinson's Disease.

The patented Gladiator Therapeutics Devices improve blood circulation and safely reduce inflammation and pain. By improving the body's circulation, the Gladiator Device provides better blood flow which can speed the healing for chronic wounds and post-surgical recovery. Indeed, when the circulatory system is running efficiently, the benefits extend beyond physical health.

Gladiator Therapeutics is dedicated to the research and innovation of non-powered far infrared (FIR) technology to develop therapies for stem cell proliferation, treating surgical post-operative and chronic wounds. The patented SemiCera(TM) Technology offers a new alternative to improve a patient's quality of life while reducing costs associated with treating wounds.

Blessed with novel technology, we continue to advance and explore medical applications through ongoing clinical trials and case studies. Our intention is to develop medical devices using this non-powered FIR technology based on scientific evidence for a variety of indications including wound healing and physical recovery from tissue damage or surgical recovery.

Wounds are associated with ranges of simple to complex disruption or damage to anatomical structure and function. They are also associated with enormous economic and social costs, increasing yearly, resulting in a severe impact on the wellbeing of individuals and society. Technology that might accelerate wound healing is associated with many benefits to injured people.

The patented Gladiator Therapeutics Devices improve blood circulation and safely reduce inflammation and pain. By improving the body's circulation, the Gladiator Device provides better blood flow which can speed the healing for chronic wounds and post-surgical recovery. Indeed, when the circulatory system is running efficiently, the benefits extend beyond physical health.

Background

Operating Room acquired pressure injury prevalence is well documented over 8% of total surgeries for procedures over 3 hours. The total cost to treat such injuries can range from $14,000 to $40,000 per patient and is not reimbursed by Medicare. Repositioning the patient during long surgeries often proves challenging, which may result in a pressure injury from prolonged pressure over bony prominences.

A 43-year-old female acquired a stage IV pressure injury over her right scapula after a 21-hour surgery. The patient had contracted necrotizing fasciitis which required extensive surgery to attempt to save her life and limbs.

The pressure injury presented the day following surgery. The wound measured 10.2 cm x 7.6 cm x 3.8 cm (length x width x depth). The wound bed was clean. Initial treatment was to pack the wound with a hydrogel gauze with a cover dressing, changed every four days.

Intervention

Gladiator Therapeutics infrared therapy was initiated to accelerate the healing of the stage IV pressure injury. Infrared therapy assists to reduce inflammation and increase microcirculation to provide the wound with greater blood flow and nutrients for faster healing. The patented infrared ceramics were utilized approximately 6 hours per day for maximum exposure.

Results

When the initial wound assessment was conducted by hospital staff, it was estimated that it would take approximately 3 months to heal a wound of this size with standard dressings.

Significant signs of improvement were noted by week two of initiating the protocol. By week three, the wound had significant granulation tissue, and the wound was approximately 50% smaller in length, width, and depth. The healing continued to progress and the wound was completely healed within 6 weeks.

Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467017/

The lead author of the study, Dr. Frederick R Carrick, Professor of Neurology at UCF COM, stated that his team used Transgenic Mice that simulate Parkinson's Disease in humans. The team found that the Parkinson's mice that were treated with the ceramics had much better control of their balance and movement. Excitingly, even normal healthy mice that were treated with the ceramics, improved their balance and movement. Dr Carrick stated that the most amazing part of their investigation was that the treatment increased the number of brain cells in the areas of the brain associated with Parkinson's Disease. They also were able increase the number of brain cells in normal healthy mice.

Wounds are associated with ranges of simple to complex disruption or damage to anatomical structure and function. They are also associated with enormous economic and social costs, increasing yearly, resulting in a severe impact on the wellbeing of individuals and society. Technology that might accelerate wound healing is associated with many benefits to injured people.

The patented Gladiator Therapeutics Devices improve blood circulation and safely reduce inflammation and pain. By improving the body's circulation, the Gladiator Device provides better blood flow which can speed the healing for chronic wounds and post-surgical recovery. Indeed, when the circulatory system is running efficiently, the benefits extend beyond physical health.

Background

Operating Room acquired pressure injury prevalence is well documented over 8% of total surgeries for procedures over 3 hours. The total cost to treat such injuries can range from $14,000 to $40,000 per patient and is not reimbursed by Medicare. Repositioning the patient during long surgeries often proves challenging, which may result in a pressure injury from prolonged pressure over bony prominences.

A 43-year-old female acquired a stage IV pressure injury over her right scapula after a 21-hour surgery. The patient had contracted necrotizing fasciitis which required extensive surgery to attempt to save her life and limbs.

The pressure injury presented the day following surgery. The wound measured 10.2 cm x 7.6 cm x 3.8 cm (length x width x depth). The wound bed was clean. Initial treatment was to pack the wound with a hydrogel gauze with a cover dressing, changed every four days.

Intervention

Gladiator Therapeutics infrared therapy was initiated to accelerate the healing of the stage IV pressure injury. Infrared therapy assists to reduce inflammation and increase microcirculation to provide the wound with greater blood flow and nutrients for faster healing. The patented infrared ceramics were utilized approximately 6 hours per day for maximum exposure.

Results

When the initial wound assessment was conducted by hospital staff, it was estimated that it would take approximately 3 months to heal a wound of this size with standard dressings.

Significant signs of improvement were noted by week two of initiating the protocol. By week three, the wound had significant granulation tissue, and the wound was approximately 50% smaller in length, width, and depth. The healing continued to progress and the wound was completely healed within 6 weeks.

Reference: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467017/

Operating Room acquired pressure injury prevalence is well documented over 8% of total surgeries for procedures over 3 hours. The total cost to treat such injuries can range from $14,000 to $40,000 per patient and is not reimbursed by Medicare. Repositioning the patient during long surgeries often proves challenging, which may result in a pressure injury from prolonged pressure over bony prominences. A 43-year-old female acquired a stage IV pressure injury over her right scapula after a 21-hour surgery. The patient had contracted necrotizing fasciitis which required extensive surgery to attempt to save her life and limbs. The pressure injury presented the day following surgery. The wound measured 10.2 cm x 7.6 cm x 3.8 cm (length x width x depth). The wound bed was clean. Initial treatment was to pack the wound with a hydrogel gauze with a cover dressing, changed every four days. Intervention Gladiator Therapeutics infrared therapy was initiated to accelerate the healing of the stage IV pressure injury. Infrared therapy assists to reduce inflammation and increase microcirculation to provide the wound with greater blood flow and nutrients for faster healing. The patented infrared ceramics were utilized approximately 6 hours per day for maximum exposure. Results When the initial wound assessment was conducted by hospital staff, it was estimated that it would take approximately 3 months to heal a wound of this size with standard dressings. Significant signs of improvement were noted by week two of initiating the protocol. By week three, the wound had significant granulation tissue, and the wound was approximately 50% smaller in length, width, and depth. The healing continued to progress and the wound was completely healed within 6 weeks.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467017/